HomeECX • FRA
Follow
Epigenomics AG
Previous close
€1.72
Day range
€1.73 - €1.78
Year range
€1.61 - €2.55
Market cap
1.63M EUR
Avg Volume
191.00
P/E ratio
-
Dividend yield
-
Primary exchange
FRA
Market news
Financials
Income Statement
Revenue
Net income
(EUR) | Jun 2023info | Y/Y change |
---|---|---|
Revenue | 70.00K | -44.44% |
Operating expense | -46.00K | -101.39% |
Net income | -2.63M | -102.38% |
Net profit margin | -3.76K | -264.29% |
Earnings per share | — | — |
EBITDA | 690.00K | 123.39% |
Effective tax rate | -0.04% | — |
Balance Sheet
Total assets
Total liabilities
(EUR) | Jun 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 3.58M | -80.14% |
Total assets | 4.22M | -79.55% |
Total liabilities | 2.31M | -41.63% |
Total equity | 1.91M | — |
Shares outstanding | 853.29K | — |
Price to book | 0.77 | — |
Return on assets | 3.63% | — |
Return on capital | 7.66% | — |
Cash Flow
Net change in cash
(EUR) | Jun 2023info | Y/Y change |
---|---|---|
Net income | -2.63M | -102.38% |
Cash from operations | -3.18M | -18.90% |
Cash from investing | 9.00K | 104.43% |
Cash from financing | -94.00K | 16.07% |
Net change in cash | -3.30M | -65.48% |
Free cash flow | -3.31M | -151.11% |
About
Epigenomics AG is a molecular diagnostics company headquartered in Berlin, Germany with a wholly owned subsidiary, Epigenomics Inc. based in Seattle, WA. Wikipedia
Founded
1998
Headquarters
Website
Employees
18